
Opinion|Podcasts|April 5, 2024
Dyskinesia: Importance of Giving Patients More Good “On- Time" in Parkinson’s Disease
Listen
0:00 / 0:00
Drs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.
Advertisement
1:30 Defining ON time in PD
4:50 Dyskinesia experience
8:15 Tremor and dyskinesia
13:40 Dyskinesia and QoL
16:10 Dyskinesia and OFF
18:35 Tailoring treatment
23:25 Amantadine DR/ER
28:50 Amantadine candidates
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Clears Roche's Single-Biomarker Elecsys pTau217 Blood Test for Alzheimer Disease
2
Factor XIa Inhibition as a Potential New Frontier in Secondary Stroke Prevention: Seemant Chaturvedi, MD
3
FDA Clears PrecivityAD2 Alzheimer Blood Test for Symptomatic Patients 40 and Older
4
FDA Accepts Ecopipam NDA for Tourette Syndrome, Remlifanserin Receives Fast Track Designation for AD Psychosis, Alterity Reaches FDA Alignment on ATH434
5

















